These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16792149)

  • 1. [The French National Medicines Assessment Committee, innovation and therapeutic progress].
    Bouvenot G
    Therapie; 2006; 61(1):13-6. PubMed ID: 16792149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Quantification of pharmacological progress by the French National Health Authorities].
    Bouvenot G
    Bull Acad Natl Med; 2006; 190(4-5):893-903; discussion 903-4. PubMed ID: 17195614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Access to medicines in France].
    Bouvenot G; Bouvenot J
    Bull Acad Natl Med; 2009 Mar; 193(3):649-59; discussion 659-62. PubMed ID: 19883016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHO expert committee on specifications for pharmaceutical preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2013; (981):i-xi, 1-188. PubMed ID: 23821930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The transparency committee of the French National Authority for Health].
    Lengliné E
    Bull Cancer; 2024 Feb; 111(2):228-234. PubMed ID: 38176970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How to adapt to the requirements of "clinical value-oriented drug innovation" for pharmaceutical research in application process of new traditional Chinese medicine].
    Jin F
    Zhongguo Zhong Yao Za Zhi; 2017 May; 42(9):1797-1802. PubMed ID: 29082710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Critical reflections on innovation, therapeutic progress and economics of health].
    Bouvenot G
    Therapie; 2001; 56(2):103-6. PubMed ID: 11471359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New drugs and indications in 2011. France is better focused on patients' interests after the Mediator scandal, but stagnation elsewhere.
    Prescrire Int; 2012 Apr; 21(126):106-10. PubMed ID: 22515141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Haute Autorite de sante opinion on cost-effectiveness of health products : results and perspectives].
    Midy F; Raimond V; Thébaut C; Sambuc C; Rumeau-Pichon C
    Sante Publique; 2015; 27(5):691-700. PubMed ID: 26752035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative advantages of new drugs: French Pharmacoeconomic Committee is not sufficiently demanding.
    Prescrire Int; 2015 Dec; 24(166):303-7. PubMed ID: 26788583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How the French national authority for health assesses medicines for use in pediatrics.
    Rebstock C; Mussetta B; Martinez S; Diatta T; Desbiolles A; Alberti C; Niaudet P; Viaux-Savelon S; Cochat P; Mercier JC
    Arch Pediatr; 2024 Jul; 31(5):285-292. PubMed ID: 38806381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2012; (970):1-235, back cover. PubMed ID: 22894011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2014; (986):1-387, back cover. PubMed ID: 24964711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-ninth report.
    World Health Organization
    World Health Organ Tech Rep Ser; 2015; (992):1-210, back cover. PubMed ID: 26118121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [State of unmet medical needs in France in 2006: necessity of reinforcing research effort].
    Jouan-Flahault C; Billon N; Castaigne A; Henry YD; Omnes C; Puech A; Rosilio M; Lassale C
    Therapie; 2007; 62(5):393-415. PubMed ID: 18206102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Europe and medicines: role of the EMEA].
    Sauer F
    Ann Pharm Fr; 2000 Jul; 58(4):278-85. PubMed ID: 10915977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.